Global DNA Probes-Based Diagnostics Market to Reach $31.1 Billion by 2030
The global market for DNA Probes-Based Diagnostics estimated at US$14.9 Billion in the year 2022, is projected to reach a revised size of US$31.1 Billion by 2030, growing at a CAGR of 9.6% over the analysis period 2022-2030. Infectious Diseases, one of the segments analyzed in the report, is projected to record a 9.5% CAGR and reach US$18.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Cancer segment is readjusted to a revised 10.5% CAGR for the next 8-year period.
The U.S. Market is Estimated at $4.4 Billion, While China is Forecast to Grow at 9% CAGR
The DNA Probes-Based Diagnostics market in the U.S. is estimated at US$4.4 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$5.4 Billion by the year 2030 trailing a CAGR of 9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.5% and 8.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR.Select Competitors (Total 46 Featured) -
- Abbott Molecular
- Beckman Coulter Inc.
- Becton, Dickinson and Company
- bioMérieux
- F. Hoffmann-La Roche Ltd.
- GE Healthcare Life Sciences
- Luminex Corporation
- QIAGEN N.V.
- Siemens Healthineers
- Thermo Fischer Scientific Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARYIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- What are DNA-Probes?
- Recent Market Activity
- DNA-based Diagnostics - A Prelude
- DNA Tests: Finding Use in Numerous Applications
- DNA Probes: Robust Growth Ahead
- Developed Markets: Traditional Revenue Contributors
- The United States: Unraveling the Country’s Edge in DNA-based Diagnostics
- Infectious Diseases Tests Dominate the DNA-based Diagnostics Market
- Developing Countries Excel in Growth Prospects
- Decoding the Genetic Puzzle
- Growth Drivers in a Nutshell
- Growth Inhibitors in a Nutshell
- Genetic Profiling of Pathogens: A Road Less Traveled
- Roche's Entry into the Hall of Molecular Fame
- DNA Technology: An Evolutionary Scan
- Tracking Landmark Breakthroughs in DNA Diagnostics: 1953-2005
- Market Opportunities
- DNA Probes-Based Diagnostics - Global Key Competitors Percentage Market Share in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
- Abbott Molecular (USA)
- Beckman Coulter, Inc. (USA)
- Becton, Dickinson and Company (USA)
- bioMérieux (France)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- GE Healthcare Life Sciences (UK)
- Luminex Corporation (USA)
- QIAGEN N.V. (Netherlands)
- Siemens Healthineers (Germany)
- Thermo Fisher Scientific, Inc. (USA)
3. MARKET TRENDS & DRIVERS
- World's Aging Population Drives the Popularity of DNA-Probe Tests
- Global Aging Population Statistics - Opportunity Indicators
- Rising Incidence of Chronic Diseases Fuels Demand for DNA Probes Based Diagnostics
- AIDS: A Global Epidemic
- Rise in Healthcare Spending in Developing Nations Bode Well for Market Growth
- Reimbursements: "Under the Umbrella"
- Evolution of New & Virulent Infectious Agents
- Challenges in Widespread Deployment of DNA-based Diagnostics
- DNA Probe Technology Gains Prominence in Diagnosing Vaginitis
- Gene Banks - A Ray of Hope for the Future
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 2: World Historic Review for DNA Probes-Based Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 3: World 18-Year Perspective for DNA Probes-Based Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2023 & 2030
- Table 4: World Recent Past, Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 5: World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 6: World 18-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
- Table 7: World Recent Past, Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 8: World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 9: World 18-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
- Table 10: World Recent Past, Current & Future Analysis for Genetic Predisposition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 11: World Historic Review for Genetic Predisposition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 12: World 18-Year Perspective for Genetic Predisposition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
- Table 13: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 14: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 15: World 18-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
- Table 16: World Recent Past, Current & Future Analysis for Identity / Forensics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 17: World Historic Review for Identity / Forensics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 18: World 18-Year Perspective for Identity / Forensics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
- Table 19: World DNA Probes-Based Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2012 through 2030
UNITED STATES
- DNA Probes-Based Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
- Table 20: USA Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 21: USA Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 22: USA 18-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2012, 2023 & 2030
CANADA
- Table 23: Canada Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 24: Canada Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 25: Canada 18-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2012, 2023 & 2030
JAPAN
- DNA Probes-Based Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
- Table 26: Japan Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 27: Japan Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 28: Japan 18-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2012, 2023 & 2030
CHINA
- DNA Probes-Based Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
- Table 29: China Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 30: China Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 31: China 18-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2012, 2023 & 2030
EUROPE
- DNA Probes-Based Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
- Table 32: Europe Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 33: Europe Historic Review for DNA Probes-Based Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 34: Europe 18-Year Perspective for DNA Probes-Based Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2023 & 2030
- Table 35: Europe Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 36: Europe Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 37: Europe 18-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2012, 2023 & 2030
FRANCE
- DNA Probes-Based Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
- Table 38: France Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 39: France Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 40: France 18-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2012, 2023 & 2030
GERMANY
- DNA Probes-Based Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
- Table 41: Germany Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 42: Germany Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 43: Germany 18-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2012, 2023 & 2030
ITALY
- Table 44: Italy Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 45: Italy Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 46: Italy 18-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2012, 2023 & 2030
UNITED KINGDOM
- DNA Probes-Based Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
- Table 47: UK Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 48: UK Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 49: UK 18-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2012, 2023 & 2030
REST OF EUROPE
- Table 50: Rest of Europe Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 51: Rest of Europe Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 52: Rest of Europe 18-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2012, 2023 & 2030
ASIA-PACIFIC
- DNA Probes-Based Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
- Table 53: Asia-Pacific Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 54: Asia-Pacific Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 55: Asia-Pacific 18-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2012, 2023 & 2030
REST OF WORLD
- Table 56: Rest of World Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 57: Rest of World Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- Table 58: Rest of World 18-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2012, 2023 & 2030
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Molecular
- Beckman Coulter Inc.
- Becton, Dickinson and Company
- bioMérieux
- F. Hoffmann-La Roche Ltd.
- GE Healthcare Life Sciences
- Luminex Corporation
- QIAGEN N.V.
- Siemens Healthineers
- Thermo Fischer Scientific Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 193 |
| Published | April 2024 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 14.9 Billion |
| Forecasted Market Value ( USD | $ 31.1 Billion |
| Compound Annual Growth Rate | 9.6% |
| Regions Covered | Global |
